These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20553255)

  • 1. Towards a rational strategy for the surveillance of patients with Lynch syndrome (hereditary non-polyposis colon cancer) for upper tract transitional cell carcinoma.
    Acher P; Kiela G; Thomas K; O'Brien T
    BJU Int; 2010 Aug; 106(3):300-2. PubMed ID: 20553255
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum.
    Mongiat-Artus P
    Eur Urol; 2008 Dec; 54(6):1235-6. PubMed ID: 18715693
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum.
    Burger M
    Eur Urol; 2008 Dec; 54(6):1236. PubMed ID: 18715704
    [No Abstract]   [Full Text] [Related]  

  • 4. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum.
    Rouprêt M; Yates DR; Comperat E; Cussenot O
    Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool.
    Audenet F; Colin P; Yates DR; Ouzzane A; Pignot G; Long JA; Soulie M; Phé V; Bensadoun H; Guy L; Ruffion A; Valeri A; Cormier L; Droupy S; de La Taille A; Saint F; Faïs PO; Houlgatte A; Cussenot O; Rouprêt M;
    BJU Int; 2012 Dec; 110(11 Pt B):E583-9. PubMed ID: 22703159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial transitional cell carcinoma and the Lynch syndrome II.
    Greenland JE; Weston PM; Wallace DM
    Br J Urol; 1993 Aug; 72(2):177-80. PubMed ID: 8402022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upper tract urothelial carcinoma: a clinicopathologic study including microsatellite instability analysis.
    Blaszyk H; Wang L; Dietmaier W; Hofstädter F; Burgart LJ; Cheville JC; Hartmann A
    Mod Pathol; 2002 Aug; 15(8):790-7. PubMed ID: 12181263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hereditary nonpolyposis colorectal cancer. Lynch syndrome].
    Luna Pérez P; Quiñónez G; Benítez-Bribiesca L; Barrientos FJ; de la Torre A
    Rev Gastroenterol Mex; 1995; 60(3):169-74. PubMed ID: 7481452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lynch syndrome in upper tract urothelial carcinoma: significance, screening, and surveillance.
    Pradere B; Lotan Y; Roupret M
    Curr Opin Urol; 2017 Jan; 27(1):48-55. PubMed ID: 27533503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options.
    Sijmons RH; Kiemeney LA; Witjes JA; Vasen HF
    J Urol; 1998 Aug; 160(2):466-70. PubMed ID: 9679899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The modern management of upper urinary tract urothelial cancer: tumour diagnosis, grading and staging.
    Painter DJ; Timoney AG; Denton K; Alken P; Keeley FX
    BJU Int; 2007 May; 99(5):973-7. PubMed ID: 17437428
    [No Abstract]   [Full Text] [Related]  

  • 12. Surveillance in Lynch syndrome: how aggressive?
    Lanspa SJ; Jenkins JX; Cavalieri RJ; Smyrk TC; Watson P; Lynch J; Lynch HT
    Am J Gastroenterol; 1994 Nov; 89(11):1978-80. PubMed ID: 7942721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and molecular diagnosis of hereditary non-polyposis colorectal cancer: problems and pitfalls in an extended pedigree.
    Ponz de Leon M; Benatti P; Percesepe A; Rossi G; Viel A; Santarosa M; Pedroni M; Roncucci L
    Ital J Gastroenterol Hepatol; 1999; 31(6):476-80. PubMed ID: 10575566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of the detection of the familial carcinoma syndrome (Lynch I and II) in the early diagnosis of colorectal carcinoma].
    Jablonská M; Rezníková L; Svitavský M; Kotrlík J; Tabach J; Hergetová H; Miková M; Svestka T
    Cas Lek Cesk; 1992 Jun; 131(11):329-33. PubMed ID: 1638599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsatellite instability and transitional cell carcinoma of the upper urinary tract.
    Rouprêt M; Azzouzi AR; Cussenot O
    BJU Int; 2005 Sep; 96(4):489-92. PubMed ID: 16104897
    [No Abstract]   [Full Text] [Related]  

  • 16. Is the phenotype mixed or mistaken? Hereditary nonpolyposis colorectal cancer and hyperplastic polyposis syndrome.
    Jarrar AM; Church JM; Fay S; Kalady MF
    Dis Colon Rectum; 2009 Dec; 52(12):1949-55. PubMed ID: 19934914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary nonpolyposis colorectal cancer--Lynch syndromes I and II.
    Lynch HT; Lanspa SJ; Boman BM; Smyrk T; Watson P; Lynch JF; Lynch PM; Cristofaro G; Bufo P; Tauro AV
    Gastroenterol Clin North Am; 1988 Dec; 17(4):679-712. PubMed ID: 3068137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
    Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
    J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of surgery in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer (Lynch syndrome).
    Smith KD; Rodriguez-Bigas MA
    Surg Oncol Clin N Am; 2009 Oct; 18(4):705-15. PubMed ID: 19793576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lynch syndrome in urological practice: diagnosis, therapeutic strategies, and screening for upper tract urothelial carcinoma.
    Lonati C; Moschini M; Simeone C; Spiess PE; Necchi A
    Curr Opin Urol; 2022 Jan; 32(1):40-47. PubMed ID: 34608026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.